CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 88 filers reported holding CONCERT PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,385,000 | -61.9% | 277,611 | -3.6% | 0.00% | -100.0% |
| Q4 2020 | $3,639,000 | +28.3% | 287,910 | -0.3% | 0.00% | 0.0% |
| Q3 2020 | $2,836,000 | -16.1% | 288,816 | -15.0% | 0.00% | 0.0% |
| Q2 2020 | $3,380,000 | -0.2% | 339,749 | -11.3% | 0.00% | -50.0% |
| Q1 2020 | $3,386,000 | +11.6% | 383,035 | +16.4% | 0.00% | +100.0% |
| Q4 2019 | $3,035,000 | +16.2% | 328,958 | -26.0% | 0.00% | 0.0% |
| Q3 2019 | $2,612,000 | -52.7% | 444,370 | -3.4% | 0.00% | -50.0% |
| Q2 2019 | $5,523,000 | – | 460,222 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |